Video Endoscopic Sequence 4 of 15
0207 386 0464 The rise of GLP-1 weight-loss injections has transformed obesity treatment in the UK but doctors are now warning of a lesser-known and increasingly common side effect: haemorrhoids
This helps distinguish thyroid-driven weight gain from genetic appetite dysregulation, allowing your provider to personalize your tirzepatide dose and formula for faster, safer results
References Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R
Long-term maintenance with periodic re-evaluation, since obesity is a chronic condition
Frail patients routinely get undertreated because clinicians fear they wont tolerate medications well. With such promising findings, Pandey says the teams next step is confirming these results with objective physical measures: the Fried frailty phenotype, Short Physical Performance Battery, grip strength, gait speed